Q4 2024 Earnings Call Transcript May 29, 2025 Roivant Sciences Ltd. misses on earnings expectations. Reported EPS is $-0.22 ...

Shares of Immunovant, Inc. (IMVT) traded 2% higher on Thursday morning after the company reported a narrower-than-expected ...

Following FDA approval of Imaavy, we explore promising biotech candidates in development for myasthenia gravis.

ouh.nhs.uk Objective To ascertain the frequency of childhood myasthenia in the UK. Specifically, we aimed to identify the detected incidence of autoimmune myasthenia and the detected prevalence of ...

Unless you have Graves’ disease, you may not be familiar with thyroid eye disease. These two conditions often occur simultaneously, affecting the same people. Graves’ disease is a condition in ...

This novel treatment approach has resulted in clinical evidence of CIC-1 inhibition in myasthenia gravis (MG) and preclinical evidence in spinal muscular atrophy, Charcot-Marie Tooth (CMT) disease and ...

Alan Jackson announced in 2021 that he had been diagnosed with Charcot-Marie-Tooth disease Jason Kempin/Getty Alan Jackson announced in 2021 that he had been diagnosed with Charcot-Marie-Tooth ...

Get inspired by a weekly roundup on living well, made simple. Sign up for CNN’s Life, But Better newsletter for information and tools designed to improve your well-being. Getting the shingles ...

said the company’s work around the launch of the prefilled syringe reflects discussions with generalized myasthenia gravis (gMG) patients. “We listened to the voices of patients in the gMG ...

Generalized myasthenia gravis is a chronic autoimmune disease that J&J estimates affects around 700,000 people worldwide. In this disease, the body makes auto-antibodies that target proteins at ...

Eating about a dozen servings of ultraprocessed food each day could more than double your risk of developing Parkinson’s disease, according to a new study. A single serving in the study was 8 ...

Imaavy is the first FcRn blocker approved for anti-AChR and anti-MuSK antibody positive patients with generalized myasthenia gravis. The Food and Drug Administration (FDA) has approved Imaavy ™ ...